Billionaire Bill Ackman Has 56% of His Hedge Fund’s $16.5 Billion Portfolio Invested in 3 Outstanding Stocks

Axsome Therapeutics has an exciting late-stage pipeline. Madrigal Pharmaceuticals is looking to dominate a large market with significant unmet needs.

Both stocks were falling as phone manufacturers scale back production plans.

AI and healthcare momentum remain strong heading into 2026. NVDA, AVGO and LLY stand out as high-growth leaders with earnings power still driving their rallies.